Register by March 26th and Save up to $350!
There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the commercial potential from large markets and the ability to pay for such treatment. Innovative approaches are being developed to stimulate interest and provide incentives for companies and other researchers to work on finding new therapeutics for diseases prevalent in developing countries. Almost all work in this field will be based on collaborations of one type or another, during discovery, drug evaluation or, when successful, delivery of treatments. This forum is designed to bring together many of the major stakeholders addressing these problems, in order to examine and discuss strategies and best practices for solving the major challenges that prevent faster and more effective solutions.
Coverage Includes:
Strategies to Improve Collaboration with Academics
Ways to Improve the Contributions of Companies in Developing Countries
Leveraging Opportunities in Developed Markets to Support Neglected Disease Products
Development of Vaccines, Anti-Virals and Other Anti-Infectives
Strategies for Sharing Intellectual Property while Still Protecting It
Best Practices for Collaboration with Developing Countries
Different Models for Funding and Incentives for Research and Development
Addressing the Challenge of Delivery in the Face of Limited Health Infrastructure
Agenda: Day 1 | Day 2
For more details on the conference, please contact:
Phillips Kuhl
President
Cambridge Healthtech Institute
T: (+1) 781-972-5410
E: pkuhl@healthtech.com
For partnering and sponsorship information, please contact:
Arnie Wolfson
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: awolfson@healthtech.com